Drug makers come up with aggressive OTC sales plan

The majority of local pharmaceutical firms set forth their business plans for 2008, largely characterized by aggressive OTC sales with all-out incentive plans, amid concerns over expected sluggish ethical sales under the possible influence of free trade agreements and a series of drug price cuts.

Domestic pharmaceutical firms are trying to seek an alternative profit source to cover the loss ...